Wound Management News

How clinicians frame the information presented to patients about dysplastic nevi diagnosis and management affects patient decision-making on surgical options, according to researchers in Journal of the American Academy of Dermatology.

Among dermatology residents, researchers saw an increase in the Objective Structured Assessment of Technical Skills instrument after implementing a video-based surgical curriculum, and residents self-reported enjoying the video-based and simulation method.

The American Society for Dermatologic Surgery awarded Roy G. Geronemus, MD, as its inaugural recipient of the Vic Narurkar, MD, Innovations in Aesthetic Dermatology Lectureship Award.

The Opioid-Prescribing in Dermatology Workgroup determined that 10% of patients or less undergoing 87 common dermatological procedures require postoperative opioid management at discharge.

WASHINGTON — Results presented at ASN Kidney Week suggested phytonadione may be a safe and effective way to treat calciphylaxis in patients on hemodialysis.

The biopharmaceutical company Mallinckrodt announced positive top-line results from its phase 3 clinical trial for StrataGraft regenerative tissue and plans to submit a biologics license application to the FDA in the first half of 2020.

Platelet-rich plasma, or PRP, appears to yield healing in ulcers as it changes the matrix metalloproteinase and cytokine expression shortly after topical application, according to researchers.

The use of salvage limited-field irradiation in aggressive cutaneous squamous cell carcinoma with microscopic residual disease resulted in a progression rate of more than 80%, which is much higher than the usual failure rate for high-risk cutaneous squamous cell carcinoma, according to findings published in JAMA Dermatology.

Numerous barriers prevent the common use of fungal preparations in the dermatology setting, such as the belief that clinical diagnosis is sufficient and the lack of a required Clinical Laboratory Improvement Amendment certification, along with the notion that it is difficult to obtain, according to recent survey findings.

Areas of disagreement between patients and physicians on skin cancer-related outcomes include patient fear of the unknown, recurrence and empowering patients to make treatment choices, according to researchers in Dermatologic Surgery.